Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Sandstrom

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Experimental Medicine|November 14, 2022
NLRP1 activation by UVB: Shedding light on an enigmatic inflammasomeAndrew Sandstrom
The Journal of Experimental Medicine|February 15, 2018
Defusing inflammasomesAndrew Sandstrom, Russell E Vance
Current Opinion in Immunology|May 24, 2019
The NLRP1 inflammasome: new mechanistic insights and unresolved mysteriesPatrick S Mitchell, Andrew Sandstrom, Russell E Vance
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2026
NLRP1B is an integrated decoy that subverts <i><i>Shigella</i> flexneri</i> E3 ligase activity to promote effector-triggered immunitySiwon Chung, Hannah Hudson, Kaitlin A Stromberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2020
Molecular characterization of a fungal gasdermin-like proteinAsen Daskalov, Patrick S Mitchell, Andrew Sandstrom, et al.
The Journal of Biological Chemistry|January 5, 2012
γδ T cell receptors recognize the non-classical major histocompatibility complex (MHC) molecule T22 via conserved anchor residues in a MHC peptide-like fashionAndrew Sandstrom, Louise Scharf, Gabrielle McRae, et al.
Nature Structural & Molecular Biology|March 8, 2011
Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteinsShahir S Rizk, Marcin Paduch, John H Heithaus, et al.
Science (New York, N.Y.)|March 16, 2019
Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymesAndrew Sandstrom, Patrick S Mitchell, Lisa Goers, et al.
The Journal of Biological Chemistry|August 1, 2012
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodiesAparna Palakodeti, Andrew Sandstrom, Lakshmi Sundaresan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunityMark M Wurfel, William Y Park, Frank Radella, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Experimental Medicine|November 14, 2022
NLRP1 activation by UVB: Shedding light on an enigmatic inflammasomeAndrew Sandstrom
The Journal of Experimental Medicine|February 15, 2018
Defusing inflammasomesAndrew Sandstrom, Russell E Vance
Current Opinion in Immunology|May 24, 2019
The NLRP1 inflammasome: new mechanistic insights and unresolved mysteriesPatrick S Mitchell, Andrew Sandstrom, Russell E Vance
Proceedings of the National Academy of Sciences of the United States of America|March 24, 2026
NLRP1B is an integrated decoy that subverts <i><i>Shigella</i> flexneri</i> E3 ligase activity to promote effector-triggered immunitySiwon Chung, Hannah Hudson, Kaitlin A Stromberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2020
Molecular characterization of a fungal gasdermin-like proteinAsen Daskalov, Patrick S Mitchell, Andrew Sandstrom, et al.
The Journal of Biological Chemistry|January 5, 2012
γδ T cell receptors recognize the non-classical major histocompatibility complex (MHC) molecule T22 via conserved anchor residues in a MHC peptide-like fashionAndrew Sandstrom, Louise Scharf, Gabrielle McRae, et al.
Nature Structural & Molecular Biology|March 8, 2011
Allosteric control of ligand-binding affinity using engineered conformation-specific effector proteinsShahir S Rizk, Marcin Paduch, John H Heithaus, et al.
Science (New York, N.Y.)|March 16, 2019
Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymesAndrew Sandstrom, Patrick S Mitchell, Lisa Goers, et al.
The Journal of Biological Chemistry|August 1, 2012
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodiesAparna Palakodeti, Andrew Sandstrom, Lakshmi Sundaresan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunityMark M Wurfel, William Y Park, Frank Radella, et al.
Pageof 2